Biosynex (France) Today
| ALBIO Stock | EUR 2.77 0.11 3.82% |
Performance0 of 100
| Odds Of DistressLess than 10
|
Biosynex is selling at 2.77 as of the 24th of November 2024; that is 3.82% down since the beginning of the trading day. The stock's last reported lowest price was 2.74. Biosynex has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for Biosynex are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of October 2024 and ending today, the 24th of November 2024. Click here to learn more.
Biosynex SA designs, manufactures, and distributes rapid diagnostic tests in France and internationally. The company was founded in 1993 and is based in Illkirch-Graffenstaden, France. BIOSYNEX is traded on Paris Stock Exchange in France. The company has 10.25 M outstanding shares. More on Biosynex
Moving together with Biosynex Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Biosynex Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Biosynex's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Biosynex or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman CEO | Larry Abensur |
| Business Concentration | Health Care, Health Care Equipment & Supplies, Diagnostics & Research, Healthcare (View all Sectors) |
Biosynex (ALBIO) is traded on Euronext Paris in France and employs 320 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 121.6 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Biosynex's market, we take the total number of its shares issued and multiply it by Biosynex's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Biosynex operates under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 10.25 M outstanding shares.
Biosynex has accumulated about 1.98 M in cash with 109.83 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.22.
Check Biosynex Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Biosynex is €121.6 Million. Biosynex retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with substantial debt, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company at some point.
Check Biosynex Ownership Details
Biosynex Risk Profiles
Although Biosynex's alpha and beta are two of the key measurements used to evaluate Biosynex's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.79 | |||
| Standard Deviation | 4.01 | |||
| Variance | 16.06 | |||
| Risk Adjusted Performance | (0.18) |
Biosynex Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Biosynex without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run ETF Categories Now
ETF CategoriesList of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
| All Next | Launch Module |
Additional Tools for Biosynex Stock Analysis
When running Biosynex's price analysis, check to measure Biosynex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biosynex is operating at the current time. Most of Biosynex's value examination focuses on studying past and present price action to predict the probability of Biosynex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biosynex's price. Additionally, you may evaluate how the addition of Biosynex to your portfolios can decrease your overall portfolio volatility.